Amazon Launches AI Platform to Speed Up Drug Discovery

Amazon recently unveiled Amazon Bio Discovery, an AI-powered platform designed to accelerate early-stage drug development.

By offering a "no-code" interface, the platform allows lab scientists to perform complex computational research without needing extensive programming skills.

This technology can dramatically reduce the time required to shortlist candidates from 18 months to just a few weeks.

Rather than replacing human expertise, the platform aims to empower scientists, addressing the global shortage of computational biologists.

By democratizing access to high-end AI research tools, Amazon is positioning itself at the forefront of pharmaceutical innovation.

Already adopted by industry giants like Bayer, this initiative represents a major evolution in how we approach healthcare research, potentially lowering the massive costs and long timelines associated with drug discovery.